Difference between revisions of "Vitronectin (TG2)"
| Line 42: | Line 42: | ||
| Reference | | Reference | ||
| [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=2461707&dopt=Abstract PMID:2461707] | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=2461707&dopt=Abstract PMID:2461707] | ||
| + | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=1692291&dopt=Abstract PMID:1692291] | ||
|- | |- | ||
| Notes | | Notes | ||
Revision as of 12:06, 25 July 2007
| Template:Infobox header| Vitronectin (TG2) | |
|---|---|
| Vitronectin (TG2) | |
| Substrate peptide name | Vitronectin (TG2) |
| Synonyms | Serum-spreading factor |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cytoskeleton |
| Swissprot ID | P04004 |
| Reactive glutamines | Q93* |
| Reactive lysines | - |
| Substrate sequence | KGNPEQTPVLK |
| Structure | 1OC0 |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:2461707 |
| Notes | *Reactive Q residues have been determined only for FXIIIa catalyzis; probably TG2 uses the same Q residues as substrates |
| Template:Infobox header | | |
.png){kind=link}